Assistance Centre: Get Specialist Medical Advice

November 23, 2016 | 228 views

International SOS’ global network of over 72,000 accredited providers in healthcare, aviation and security providers ensures we have "boots on the ground’ to support your mobile workforce, should they need it. Find out how your people can access to the best possible expertise for any question or emergency through our 24/7 Assistance Centres.

Spotlight

Health Forum

Health Forum’s trusted and award winning information, education and media empower health care providers, suppliers, payers and consumers with new insights, knowledge and learning. As a subsidiary of AHA, we are a center for the exchange of credible information, insights and data to help hospital management and suppliers improve performance. We embrace innovation and knowledge where the leaders of hospitals, health systems and their suppliers are committed to improvement and trusted by their communities.

OTHER ARTICLES
HEALTH TECHNOLOGY

Wearable Technology: A Pool of Opportunities in Healthcare

Article | August 12, 2022

Introduction The field of smart wearable devices has advanced significantly in recent years as a result of the advent of mobile medicine, the development of new technologies like smart sensing, and the increased penetration of personalized health concepts. These Internet of Things (IoT)-based smart devices not only help people pursue a healthier lifestyle, but also offer a constant flow of healthcare data, which can be used for disease diagnosis and treatment, by actively recording, tracking, and monitoring metabolic status and physiological parameters. Wearable technologies have the potential to completely change the ways to monitor health behavior and are increasingly finding clinical implementation for patients with various types of diseases. Wearable Technology: New Ways of Patient Monitoring While wearable technology has demonstrated value in the fields of entertainment, fitness, and gaming, it is making inroads into the healthcare industry at a rapid pace. Increasing advancements in sensor technology and artificial intelligence (AI) are assisting millions of people in detecting and managing chronic health conditions and avoiding serious illnesses using devices that are as small as a patch the size of a penny or small enough to be worn on the wrist. According to a study, nearly 320 million consumer health and wellness wearable devices are estimated to be shipped across the globe in 2022, and the number is likely to surpass 440 million units as a number of new devices come out and more healthcare providers start using them. Most wearable devices, such as smartwatches, now include heart rate monitors, and some have FDA approval for detecting abnormalities such as atrial fibrillation, a major cause of stroke. As these devices become more intelligent, the percentage of patients and consumers who use them to manage chronic health conditions and diagnose symptoms of serious diseases is likely to rise. This is expected to assist the sales of wearable devices in healthcare to exceed $195 billion by the end of 2027, presenting huge prospects for healthcare equipment providers and associated companies to benefit from the opportunity. The Future of Wearable Technology in Healthcare Though wearable technology is experiencing rapid growth, the field is still considered to be in its nascent stage, presenting massive remunerative prospects for the manufacturers of smart devices, especially in the healthcare industry. Hence, companies of all kinds, from giants to upstarts, are emphasizing on investing and developing new wearable devices with new features and functionalities to meet the surging demand for wearables across healthcare in coming years.

Read More
HEALTH TECHNOLOGY

The Long-Term Care Software: Mapping the Future

Article | September 28, 2022

Long-term care comprises all the health services that help patients with chronic illnesses or disabilities meet their medical and non-medical needs. It caters to those who cannot care for themselves for extended durations. For care providers, it becomes critical to meet the needs of patients on time while delivering top-notch quality, especially at a time when virtual care is more important than ever. To remedy this, many of the tasks and processes within long-term care are supported by digital solutions. These long-term care software applications enable care providers to automate aspects of patient scheduling, inventory control, regulation and compliance, data management, care delivery management, and much more. Some of the end users of long-term care software include home healthcare agencies, nursing homes, and residential hospice care facilities. What is Driving the Growth of Long-Term Care Solutions? Digitalization has swept the healthcare industry, and medical technology now occupies a significant area of medical care delivery. With the demand for a robust healthcare infrastructure aggravated by a shortage of medical professionals, the need for automation is driving the growth of medtech across all areas of healthcare. In addition, fewer medical specialists and medical cost reduction initiatives combined are powering the long-term care software market’s growth. Challenges for the Long-Term Care Software Market Despite the rapid growth in the use of digital solutions to manage administrative and compliance tasks, technological transformations are expensive. The high maintenance costs incurred by care providers are a major hindrance towards a full-fledged adoption. Many care providers are also unwilling to adopt new applications due to the implementation and staff training costs involved in doing so. What the Future Holds? With an increase in remote care and the use of technologies like the Internet of Medical Things to deliver diagnostic services and preventive care, medtech is witnessing a revolution. Long-term care is bound to follow suit thanks to areas like remote patient monitoring and wearable technology. While the long-term care market is slated to grow by leaps and bounds, solution makers must find a way to help care providers warm up to the use of technology and de

Read More
HEALTH TECHNOLOGY

Amazon Care: Revolutionizing Virtual Care

Article | August 29, 2022

In 2021, the introduction of Amazon Care marked the first time a prominent technology firm stepped into the healthcare services industry. The fact that Amazon filed paperwork to offer care in multiple states without much fanfare is intriguing. In March 2021, the company confirmed the details of its new services, announcing that it would be delivering the services through an independent private medical practice called Care Medical. The move may signify another diversification for Amazon, but what does it mean for the healthcare services landscape? The Highlights of Amazon Care’s Services Home healthcare Amazon announced that it would be participating in an advocacy group for home healthcare. The Moving Health at Home initiative aims to transform how policymakers view the home as a site to deliver clinical services. Amazon Care may be riding on the trend for home care that has been evolving in the form of remote patient monitoring for post-acute care management and chronic care. Employer-oriented offering Amazon Care aims to become a workplace benefit partner for employers. One of the pain points it is directly addressing is the challenge of runaway inflation that increases healthcare costs. Virtual care simplified The most significant offering that Amazon Care plans to lead with is virtual care that promises to reduce wait times for quality patient care to under 60 seconds. It also includes the option to access 24-hour care services through messaging and video calling. In addition, it eliminates unnecessary traveling and long wait times by delivering care in the comfort of the patient’s home. The Path Ahead Amazon is known for introducing a slew of initiatives in the health and fitness sector, like the Halo wearables, a data management product called Amazon Health Lake, and a healthcare delivery system called Haven, which doubled over in 2021 after a three-year run. However, the tech juggernaut is not about to stop attempting to disrupt healthcare services. Only time will tell whether Amazon Care finally proves to be a feather in Amazon’s healthcare cap or another ambitious project that bites the dust.

Read More
HEALTH TECHNOLOGY

3 IT Investment Strategies Hospitals Can Use to Improve Patient Care

Article | July 5, 2022

Rural, community, and independent hospitals are constantly facing mounting challenges in the form of staff shortages, accessibility to patient care and a multitude of cost concerns. Getting even one of these areas under control can help hospitals drastically boost their outcomes. Here are three areas of IT investment that hospitals must control to go beyond staying functional and create an excellent patient experience. Telehealth for Staff Shortage Healthcare currently face massive staff shortage with a projected gap of up to 48,000 primary care physicians and up to 77,100 specialty physicians till 2034. The effects of this shortage could be lessened by using virtual care, which would allow hospitals to care for patients through remote staffing. Digitalizing Patient Care with Asynchronous Telehealth Async telehealth of patients sending photos and videos to fast-track diagnosis. Async telehealth makes it easier for doctors to connect with more patients. This shortens the time it takes to see specialists and get important care services. Remote Patient Monitoring According to a CDC report, 90% of all healthcare spending goes into treating chronic conditions. Considering that U.S. nonmetropolitan areas have a high number of patients diagnosed with chronic conditions, accessibility is one of the contributing factors. Remote patient monitoring enhances patient care for people with chronic conditions. Wearable medical devices are already driving the move towards remote patient monitoring. Whether it’s through wearable weight scales, heart monitors, blood pressure bands, or pulse oximeters, clinicians can generate regular updates about a patient’s health readings and ensure a timely response in order to avert complications. Conclusion There is much to be achieved on the healthcare front when it comes to digitalizing care. The above technologies are enabling healthcare providers take delivery of medical care further than ever and ensure they generate more traction from their IT investments in these areas of medtech.

Read More

Spotlight

Health Forum

Health Forum’s trusted and award winning information, education and media empower health care providers, suppliers, payers and consumers with new insights, knowledge and learning. As a subsidiary of AHA, we are a center for the exchange of credible information, insights and data to help hospital management and suppliers improve performance. We embrace innovation and knowledge where the leaders of hospitals, health systems and their suppliers are committed to improvement and trusted by their communities.

Related News

DIGITAL HEALTHCARE

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Nemaura Medical, Inc | January 14, 2022

Nemaura Medical, Inc.(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the launch for employers and insurers of Miboko, a new metabolic health program using a non-invasive glucose sensor along with an AI mobile application. The Company’s goal is to achieve broad adoption of Miboko as a form of preventative medicine for a wide user base through these commercial channels and is aligned with the general trend in consumer digital healthcare. “Introducing Miboko to the population at-large through employers and insurers will allow Nemaura to reach a much wider audience in much faster fashion than solely relying on a direct-to-consumer campaign, and in the Western world, these institutions are the most reliable gateway toward wider adoption of preventative health maintenance practices. Being aware of one’s metabolic health and how the body uniquely regulates sugar is key to one’s health. Patients, of course, want to be as informed as possible about their health, and employers and insurers are also aligned with patients in that regard, given the massive productivity losses and healthcare costs at stake on a larger scale across their employee and insured base, respectively. Miboko can help address this substantial market opportunity through our non-invasive, revolutionary approach to healthcare.” Nemaura CEO Dr. Faz Chowdhury Nemaura has also submitted a Premarket Approval (PMA) to the United States Food and Drug Administration (FDA) for approval of its glucose monitoring device as a Class 3 medical device. The Company’s PMA was the subject an on-site FDA bioresearch monitoring (BIMO) audit that generated a single Form 483 observation, for which the Company has committed to a full response this quarter. A follow-up BIMO audit of the clinical investigator site has also been scheduled for the current financial quarter. Miboko has been in development for nearly two years and addresses a significant mass market opportunity that the Company believes could benefit roughly a third to half of the population by using a non-invasive glucose sensor to measure and monitor a user’s metabolic health score, which is based on glucose tolerance or insulin resistance. Those with prediabetes or obesity concerns -- or even those looking to maintain better health through more careful glucose control -- may benefit from such a metabolic health program. How one’s body metabolizes sugar is the main influencer of one’s appetite, weight, sleep quality, and energy and mood levels and even plays a critical factor in chronic diseases (beyond just diabetes), such as heart disease and dementia. At the heart of the Miboko offering is Nemaura’s non-invasive glucose sensor that is designed to measure insulin resistance, reported as a metabolic health score, and priced to be highly affordable with the program running for an initial two-year period. The program also uses a mobile app to provide users with personalized information by tracking their metabolism. A user can find out how well their body responds to sugar through their metabolic health score — and how what they eat and what they do every day uniquely affects their metabolic health. Along with the capability to follow metabolic health progress on the app, Miboko users receive weekly and monthly reports that show and explain their body’s unique metabolic health score and a breakdown of how each of their habits are impacting their overall health and wellbeing. Suggestions for small, manageable changes to daily routines, such as eating more or less of a certain kind of food or exercising at a different time of day to coincide with peak energy levels, provide Miboko users with personalized, usable data. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the U.S. as a general wellness product as part of its BEAT®diabetes program that is currently undergoing pilot studies. Additionally, Nemaura has launched Miboko, a new metabolic health and well-being program using a non-invasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. The Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023.

Read More

AI

HALO Diagnostics Launches Subtle Medical's Suite of AI-powered Imaging Technologies for Better Patient Care

Subtle Medical | October 06, 2021

HALO Diagnostics (formerly Desert Medical Imaging), a leading medical imaging provider headquartered in Southern California, announced today a partnership with Subtle Medical, a healthcare technology company focused on AI-powered software solutions that enable faster, safer, and smarter medical imaging. HALO has implemented both SubtleMR™ and SubtlePET™ image enhancement software at multiple locations, leading to higher quality imaging and improved patient experience. "With Subtle's technology, we now have the ability to restore image quality to standard of care when conducting shorter scan times for MRI and PET and lower dose PET exams. This combination allows us to better tailor scans to patient needs and improve workflow efficiency, patient experience, and patient safety. The addition of Subtle Medical's technology to HALO Diagnostics furthers our commitment to precision focused, personalized healthcare." MD, Chief Medical Officer at HALO Diagnostics HALO Diagnostics is focused on saving and extending the quality of people's lives through the early detection of the leading causes of death with precision diagnostics. Combining leaders from the medical, scientific and high technology communities, HALO Diagnostics is a leader in the early detection of cancer's like Prostate and Breast in men and women. "We could not be more pleased that Halo Diagnostics has adopted both SubtleMR and SubtlePET. Our unique technology not only supports a better patient experience from less time in the imaging suite, but also increased perceived safety. We look forward to a long partnership with Halo". Chief Commercial Officer for Subtle Medical Subtle Medical has an extensive product pipeline. The company's technologies utilize proprietary deep learning algorithms that integrate seamlessly with any OEM scanner to improve image quality from accelerated image acquisition without any alteration in the imaging specialists' workflow. About HALO HALO Diagnostics (HALO Dx, Inc.) changes patient lives and outcomes through early detection of the leading causes of death with precision diagnostics. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale combined with deep learning algorithms. By optimizing all these solutions under the HALO Diagnostics platform, we provide rapid, precise, actionable results to enable life-changing treatments by physicians for their patients. About Subtle Medical Subtle Medical, Inc. is an innovative healthcare technology company with a suite of software solutions that use deep learning to increase the quality and efficiency of medical imaging. Subtle's software solutions are integrated at hospitals and imaging institutions worldwide. It was named a CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.

Read More

Star Trek stethoscopes? What next-gen med students need to know

Star Trek | August 09, 2017

Hundreds of miles away, our patient has just used his personal Tricorder yes, like the ones in Star Trek for the daily evaluation of his systems. Just like on the U.S.S. Enterprise, the tricorder quickly compares the patient’s biometric information against his personal records, as well as a global database, to identify anomalies and risks to wellness. Culling through millions of algorithms in the blink of an eye, the artificial intelligence AI program determines a series of diagnoses and sets about corrective treatment.

Read More

DIGITAL HEALTHCARE

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Nemaura Medical, Inc | January 14, 2022

Nemaura Medical, Inc.(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the launch for employers and insurers of Miboko, a new metabolic health program using a non-invasive glucose sensor along with an AI mobile application. The Company’s goal is to achieve broad adoption of Miboko as a form of preventative medicine for a wide user base through these commercial channels and is aligned with the general trend in consumer digital healthcare. “Introducing Miboko to the population at-large through employers and insurers will allow Nemaura to reach a much wider audience in much faster fashion than solely relying on a direct-to-consumer campaign, and in the Western world, these institutions are the most reliable gateway toward wider adoption of preventative health maintenance practices. Being aware of one’s metabolic health and how the body uniquely regulates sugar is key to one’s health. Patients, of course, want to be as informed as possible about their health, and employers and insurers are also aligned with patients in that regard, given the massive productivity losses and healthcare costs at stake on a larger scale across their employee and insured base, respectively. Miboko can help address this substantial market opportunity through our non-invasive, revolutionary approach to healthcare.” Nemaura CEO Dr. Faz Chowdhury Nemaura has also submitted a Premarket Approval (PMA) to the United States Food and Drug Administration (FDA) for approval of its glucose monitoring device as a Class 3 medical device. The Company’s PMA was the subject an on-site FDA bioresearch monitoring (BIMO) audit that generated a single Form 483 observation, for which the Company has committed to a full response this quarter. A follow-up BIMO audit of the clinical investigator site has also been scheduled for the current financial quarter. Miboko has been in development for nearly two years and addresses a significant mass market opportunity that the Company believes could benefit roughly a third to half of the population by using a non-invasive glucose sensor to measure and monitor a user’s metabolic health score, which is based on glucose tolerance or insulin resistance. Those with prediabetes or obesity concerns -- or even those looking to maintain better health through more careful glucose control -- may benefit from such a metabolic health program. How one’s body metabolizes sugar is the main influencer of one’s appetite, weight, sleep quality, and energy and mood levels and even plays a critical factor in chronic diseases (beyond just diabetes), such as heart disease and dementia. At the heart of the Miboko offering is Nemaura’s non-invasive glucose sensor that is designed to measure insulin resistance, reported as a metabolic health score, and priced to be highly affordable with the program running for an initial two-year period. The program also uses a mobile app to provide users with personalized information by tracking their metabolism. A user can find out how well their body responds to sugar through their metabolic health score — and how what they eat and what they do every day uniquely affects their metabolic health. Along with the capability to follow metabolic health progress on the app, Miboko users receive weekly and monthly reports that show and explain their body’s unique metabolic health score and a breakdown of how each of their habits are impacting their overall health and wellbeing. Suggestions for small, manageable changes to daily routines, such as eating more or less of a certain kind of food or exercising at a different time of day to coincide with peak energy levels, provide Miboko users with personalized, usable data. About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the U.S. as a general wellness product as part of its BEAT®diabetes program that is currently undergoing pilot studies. Additionally, Nemaura has launched Miboko, a new metabolic health and well-being program using a non-invasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. The Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023.

Read More

AI

HALO Diagnostics Launches Subtle Medical's Suite of AI-powered Imaging Technologies for Better Patient Care

Subtle Medical | October 06, 2021

HALO Diagnostics (formerly Desert Medical Imaging), a leading medical imaging provider headquartered in Southern California, announced today a partnership with Subtle Medical, a healthcare technology company focused on AI-powered software solutions that enable faster, safer, and smarter medical imaging. HALO has implemented both SubtleMR™ and SubtlePET™ image enhancement software at multiple locations, leading to higher quality imaging and improved patient experience. "With Subtle's technology, we now have the ability to restore image quality to standard of care when conducting shorter scan times for MRI and PET and lower dose PET exams. This combination allows us to better tailor scans to patient needs and improve workflow efficiency, patient experience, and patient safety. The addition of Subtle Medical's technology to HALO Diagnostics furthers our commitment to precision focused, personalized healthcare." MD, Chief Medical Officer at HALO Diagnostics HALO Diagnostics is focused on saving and extending the quality of people's lives through the early detection of the leading causes of death with precision diagnostics. Combining leaders from the medical, scientific and high technology communities, HALO Diagnostics is a leader in the early detection of cancer's like Prostate and Breast in men and women. "We could not be more pleased that Halo Diagnostics has adopted both SubtleMR and SubtlePET. Our unique technology not only supports a better patient experience from less time in the imaging suite, but also increased perceived safety. We look forward to a long partnership with Halo". Chief Commercial Officer for Subtle Medical Subtle Medical has an extensive product pipeline. The company's technologies utilize proprietary deep learning algorithms that integrate seamlessly with any OEM scanner to improve image quality from accelerated image acquisition without any alteration in the imaging specialists' workflow. About HALO HALO Diagnostics (HALO Dx, Inc.) changes patient lives and outcomes through early detection of the leading causes of death with precision diagnostics. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale combined with deep learning algorithms. By optimizing all these solutions under the HALO Diagnostics platform, we provide rapid, precise, actionable results to enable life-changing treatments by physicians for their patients. About Subtle Medical Subtle Medical, Inc. is an innovative healthcare technology company with a suite of software solutions that use deep learning to increase the quality and efficiency of medical imaging. Subtle's software solutions are integrated at hospitals and imaging institutions worldwide. It was named a CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.

Read More

Star Trek stethoscopes? What next-gen med students need to know

Star Trek | August 09, 2017

Hundreds of miles away, our patient has just used his personal Tricorder yes, like the ones in Star Trek for the daily evaluation of his systems. Just like on the U.S.S. Enterprise, the tricorder quickly compares the patient’s biometric information against his personal records, as well as a global database, to identify anomalies and risks to wellness. Culling through millions of algorithms in the blink of an eye, the artificial intelligence AI program determines a series of diagnoses and sets about corrective treatment.

Read More

Events